209 related articles for article (PubMed ID: 30053706)
21. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy.
Butler SF; Budman SH; Fanciullo GJ; Jamison RN
Clin J Pain; 2010; 26(9):770-6. PubMed ID: 20842012
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of the Opioid Compliance Checklist to Monitor Chronic Pain Patients Receiving Opioid Therapy in Primary Care.
Jamison RN; Martel MO; Huang CC; Jurcik D; Edwards RR
J Pain; 2016 Apr; 17(4):414-23. PubMed ID: 26705974
[TBL] [Abstract][Full Text] [Related]
23. Reappraisal deficits promote craving and emotional distress among chronic pain patients at risk for prescription opioid misuse.
Garland EL; Hanley AW; Bedford CE; Zubieta JK; Howard MO; Nakamura Y; Donaldson GW; Froeliger B
J Addict Dis; 2018; 37(1-2):14-22. PubMed ID: 29863439
[No Abstract] [Full Text] [Related]
24. Risk for Opioid Misuse Among Emergency Department Cancer Patients.
Reyes-Gibby CC; Anderson KO; Todd KH
Acad Emerg Med; 2016 Feb; 23(2):151-8. PubMed ID: 26824227
[TBL] [Abstract][Full Text] [Related]
25. Impulsivity but not sensation seeking is associated with opioid analgesic misuse risk in patients with chronic pain.
Marino EN; Rosen KD; Gutierrez A; Eckmann M; Ramamurthy S; Potter JS
Addict Behav; 2013 May; 38(5):2154-7. PubMed ID: 23454878
[TBL] [Abstract][Full Text] [Related]
26. Do pain patients at high risk for substance misuse experience more pain? A longitudinal outcomes study.
Jamison RN; Link CL; Marceau LD
Pain Med; 2009 Sep; 10(6):1084-94. PubMed ID: 19671087
[TBL] [Abstract][Full Text] [Related]
27. To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patients.
Tompkins DA; Huhn AS; Johnson PS; Smith MT; Strain EC; Edwards RR; Johnson MW
Addiction; 2018 Jan; 113(1):67-79. PubMed ID: 28645137
[TBL] [Abstract][Full Text] [Related]
28. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline.
Chou R; Fanciullo GJ; Fine PG; Miaskowski C; Passik SD; Portenoy RK
J Pain; 2009 Feb; 10(2):131-46. PubMed ID: 19187890
[TBL] [Abstract][Full Text] [Related]
29. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
Setnik B; Roland CL; Pixton GC; Sommerville KW
Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
[TBL] [Abstract][Full Text] [Related]
30. Anxiety sensitivity and pain intensity independently predict opioid misuse and dependence in chronic pain patients.
Smit T; Rogers AH; Garey L; Allan NP; Viana AG; Zvolensky MJ
Psychiatry Res; 2020 Dec; 294():113523. PubMed ID: 33189986
[TBL] [Abstract][Full Text] [Related]
31. Systematic review to determine which validated measurement tools can be used to assess risk of problematic analgesic use in patients with chronic pain.
Lawrence R; Mogford D; Colvin L
Br J Anaesth; 2017 Dec; 119(6):1092-1109. PubMed ID: 28981581
[TBL] [Abstract][Full Text] [Related]
32. Validation of a screener and opioid assessment measure for patients with chronic pain.
Butler SF; Budman SH; Fernandez K; Jamison RN
Pain; 2004 Nov; 112(1-2):65-75. PubMed ID: 15494186
[TBL] [Abstract][Full Text] [Related]
33. Chronic Pain and Risk Factors for Opioid Misuse in a Palliative Care Clinic.
Childers JW; King LA; Arnold RM
Am J Hosp Palliat Care; 2015 Sep; 32(6):654-9. PubMed ID: 24744398
[TBL] [Abstract][Full Text] [Related]
34. Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center.
Yennurajalingam S; Edwards T; Arthur JA; Lu Z; Najera J; Nguyen K; Manju J; Kuriakose L; Wu J; Liu D; Williams JL; Reddy SK; Bruera E
Cancer; 2018 Oct; 124(19):3942-3949. PubMed ID: 30192372
[TBL] [Abstract][Full Text] [Related]
35. Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain.
Passik SD; Narayana A; Yang R
Pain Med; 2014 Aug; 15(8):1365-72. PubMed ID: 24666664
[TBL] [Abstract][Full Text] [Related]
36. Opioid attentional bias and cue-elicited craving predict future risk of prescription opioid misuse among chronic pain patients.
Garland EL; Howard MO
Drug Alcohol Depend; 2014 Nov; 144():283-7. PubMed ID: 25282309
[TBL] [Abstract][Full Text] [Related]
37. A comparison of an opioid abuse screening tool and prescription drug monitoring data in the emergency department.
Weiner SG; Horton LC; Green TC; Butler SF
Drug Alcohol Depend; 2016 Feb; 159():152-7. PubMed ID: 26743334
[TBL] [Abstract][Full Text] [Related]
38. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM).
Meltzer EC; Rybin D; Saitz R; Samet JH; Schwartz SL; Butler SF; Liebschutz JM
Pain; 2011 Feb; 152(2):397-402. PubMed ID: 21177035
[TBL] [Abstract][Full Text] [Related]
39. Health Literacy, Opioid Misuse, and Pain Experience Among Adults with Chronic Pain.
Rogers AH; Bakhshaie J; Orr MF; Ditre JW; Zvolensky MJ
Pain Med; 2020 Apr; 21(4):670-676. PubMed ID: 30938818
[TBL] [Abstract][Full Text] [Related]
40. Shortening the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A Proof-of-Principle Study for Customized Computer-Based Testing.
Finkelman MD; Kulich RJ; Zacharoff KL; Smits N; Magnuson BE; Dong J; Butler SF
Pain Med; 2015 Dec; 16(12):2344-56. PubMed ID: 26176496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
